rTMS治疗PD的安全性问题
rTMS总体上是安全无创的,仅有少数报道患者发生不良反应。有文献[23]回顾了77项共纳入1137例PD患者的rTMS研究,发现无论哪种设计方案,不良反应的发生风险都较低(人均风险为0.040,95%CI 为0.029~0.053)。这些不良反应包括一过性头痛(7例)、头皮疼痛(17例)、耳鸣、恶心(1例)、肌肉抽搐等,无癫痫发作报道。最近的荟萃分析中有13项研究涉及安全性评估,无一报道有严重的不良反应发生[15]。更有122 例接受丘脑底核深部刺激手术的患者,给予TMS或rTMS干预后没有发生不良反应[23]。尽管如此,在PD患者中进行rTMS治疗时,仍然需要遵守TMS安全性指南[24],并注意在施行rTMS 前筛查患者的用药史和既往史(特别是心脏病和癫痫)。
总之,现有研究表明,rTMS对于PD的运动症状、运动并发症、非运动症状均有一定的应用价值,表现出乐观的治疗前景。其安全、无创、操作简单的特点更为其临床应用的开展提供了有利条件。虽然目前尚无公认的治疗方案,但M1区高频刺激改善运动症状、SMA区或小脑低频刺激改善LID、DLPFC 区高频刺激改善非运动症状的趋势已初见端倪。由于人脑的复杂性和病理生理状态对脑功能的影响,因此研究健康人的结论还不能照搬到临床。未来人们需要开展大规模多中心的RCT研究,以进一步形成一致性的治疗方案,并发掘其应用价值。
参考文献
[1]中华医学会神经病学分会PD及运动障碍学组.中国PD治疗指南[J].中华神经科杂志,2014,47(6):1-6.
[2]Hayashi T,Ohnishi T,Okabe S,et al.Long-term effect of motor cortical repetitive transcranial magnetic stimulation[J].Ann Neurol,2004,56(1):77-85.
[3]Platz T,Rothwell JC.Brain stimulation and brain repair rTMS:from animal experiment to clinical trials—what do we know?[J].Restor Neurol Neurosci,2010,28(4):387-398.
[4]Morgante F,Espay AJ,Gunraj C,et al.Motor cortex plasticity in Parkinson's disease and levodopa-induced dyskinesias[J].Brain,2006,129(Pt 4):1059-1069.
[5]Sen S,Kawaguchi A,Truong Y,et al.Dynamic changes in cerebellothalamo - cortical motor circuitry during progression of Parkinson ' s disease[J].Neuroscience,2010,166(2):712-719.
[6]Kishore A,Meunier S,Popa T.Cerebellar influence on motor cortex plasticity:behavioral implications for Parkinson's disease[J].Front Neurol,2014,5:68.
[7]Kishore A,Popa T.Cerebellum in levodopa-induced dyskinesias:the unusual suspect in the motor network[J].Front Neurol,2014,5:157.
[8]Ni Z,Bahl N,Gunraj CA,et al.Increased motor cortical facilitation and decreased inhibition in Parkinson disease[J].Neurology,2013,80(19):1746-1753.
[9]Koch G,Brusa L,Caltagirone C,et al.rTMS of supplementary motor area modulates therapy-induced dyskinesias in Parkinson disease[J].Neurology,2005,65(4):623-625.
[10]Brusa L,Versace V,Koch G,et al.Low frequency rTMS of the SMA transiently ameliorates peak-dose LID in Parkinson's disease[J].Clin Neurophysiol,2006,117(9):1917-1921.
[11]Strafella AP,Paus T,Fraraccio M,et al.Striatal dopamine release induced by repetitive transcranial magnetic stimulation of the human motor cortex[J].Brain,2003,126(Pt 12):2609-2615.(https://www.daowen.com)
[12]Arias-Carrion O.Basic mechanisms of rTMS:Implications in Parkinson's disease[J].Int Arch Med,2008,1(1):2.
[13]Pascual-Leone A,Valls-Solé J,Brasil-Neto JP,et al.Akinesia in Parkinson's disease.II.Effects of subthreshold repetitive transcranial motor cortex stimulation[J].Neurology,1994,44(5):892-898.
[14]Elahi B,Chen R.Effect of transcranial magnetic stimulation on Parkinson motor function—systematic review of controlled clinical trials[J].Mov Disord,2009,24(3):357-363.
[15]Chou YH,Hickey PT,Sundman M,et al.Effects of repetitive transcranial magnetic stimulation on motor symptoms in Parkinson disease:a systematic review and meta-analysis[J].JAMA Neurol,2015,72(4):432-440.
[16]Sayin S,Cakmur R,Yener GG,et al.Low - frequency repetitive transcranial magnetic stimulation for dyskinesia and motor performance in Parkinson's disease[J].J Clin Neurosci,2014,21(8):1373-1376.
[17]Filipovic SR,Rothwell JC,van de Warrenburg BP,et al.Repetitive transcranial magnetic stimulation for levodopa-induced dyskinesias in Parkinson's disease[J].Mov Disord,2009,24(2):246-253.
[18]Kodama M,Kasahara T,Hyodo M,et al.Effect of low - frequency repetitive transcranial magnetic stimulation combined with physical therapy on L-dopainduced painful off-period dystonia in Parkinson's disease[J].Am J Phys Med Rehabil,2011,90(2):150-155.
[19]Koch G,Brusa L,Carrillo F,et al.Cerebellar magnetic stimulation decreases levodopa-induced dyskinesias in Parkinson disease[J].Neurology,2009,73(2):113-119.
[20]Fregni F,Santos CM,Myczkowski ML,et al.Repetitive transcranial magnetic stimulation is as effective as fluoxetine in the treatment of depression inpatients with Parkinson's disease[J].J Neurol Neurosurg Psychiatry,2004,75(8):1171-1174.
[21]Pal E,Nagy F,Aschermann Z,et al.The impact of left prefrontal repetitive transcranial magnetic stimulation on depression in Parkinson's disease:a randomized,double-blind,placebo-controlled study[J].Mov Disord,2010,25(14):2311-2317.
[22]Anderkova L,Rektorova I.Cognitive effects of repetitive transcranial magnetic stimulation in patients with neurodegenerative diseases - clinician ' s perspective[J].J Neurol Sci,2014,339(1/2):15-25.
[23]Vonloh M,Chen R,Kluger B.Safety of transcranial magnetic stimulation in Parkinson's disease:a review of the literature[J].Parkinsonism Relat Disord,2013,19(6):573-585.
[24]Rossi S,Hallett M,Rossini PM,et al.Safety,ethical considerations,and application guidelines for the use of transcranial magnetic stimulation in clinical practice and research[J].Clin Neurophysiol,2009,120(12):2008-2039.
(王 含)